The wait for Weebit Nano’s first revenue is over as a massive milestone is achieved!
Nick Sundich, November 6, 2023
Investors waiting for Weebit Nano’s (ASX:WBT) first revenue need not wait any longer! The ASX‘s most advanced semiconductor developer just announced that it has achieved this milestone.
Weebit Nano’s first revenue
WBTis following a licensing model for its ReRAM technology, based on royalties on sales, a figure which could be 1.5-3%, based on industry standards.
To illustrate how this might work, let’s assume a foundry can make a chip using WBT’s technology that costs US$10 per unit and WBT receives a 3% royalty on all sales of chips that use its technology. If the foundry sells 1m of these chips and generates US$10m in sales, WBT would receive US$300,000 from this customer for this product.
Weebit Nano received an initial licensing fee of US$100,000. While this initial revenue is small, it is an important milestone nonetheless – marking the company’s transition to commercialisation. It is a ‘pre-revenue’ company no longer. And more of these license fees will follow in the future.
Onwards and upwards for 2024
Despite the difficult year in the equity markets, it has been a year of progress for Weebit Nano and we think it has shown in the fact that shares are up over 40% in the last 12 months, even after having come down from the approximate $9 peak in March 2023.
Weebit Nano (ASX:WBT) share price chart, log scale (Source: TradingView)
Most importantly, the company commercialised its ReRAM technology with SkyWater (hence, its inaugural revenue) and signed on a second top tier fab as a partner in South Korean headquartered DB HiTek.
We believe, there is a lot more for investors to look forward to in the months ahead, including more partnerships with top tier fabs and more revenues.
Check out the research coverage of Weebit Nano by our parent company Pitt Street Research!
Disclosure: Stocks Down Under directors and staff own shares in Weebit Nano
What are the Best stocks to invest in right now?
Check our buy/sell stock tips
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Trump vs. Jerome Powell: What Happens to the Market If Powell Is Fired?
The relationship between President Donald Trump and Federal Reserve Chair Jerome Powell has often been tumultuous, particularly around decisions regarding…
Telix Pharmaceuticals (ASX:TLX): It’s made ~A$1.7bn in revenue from Illucix, but here’s why the best is yet to come!
What would you have thought if you were told 5 years ago you would see Telix Pharmaceuticals as a successful…
Anti Woke ETFs: Do they practice what they preach and have they outperformed since Trump’s return to power?
Have you ever heard of so-called ‘Anti Woke ETFs’? If you’re sick of companies that are big on ESG, this…